LA PHARMACIE DU FOUSSERET : revenue, balance sheet and financial ratios

LA PHARMACIE DU FOUSSERET is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE FOUSSERET (31430), this company of category PME shows in 2021 a revenue of 2.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LA PHARMACIE DU FOUSSERET (SIREN 538086596)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C 2 360 354 € 2 114 925 € 1 959 053 € 1 920 779 € 1 900 041 € 1 899 418 €
Net income 104 527 € 88 214 € 144 440 € 218 633 € 178 907 € 133 008 € 156 291 € 169 658 € 158 952 € 147 973 €
EBITDA N/C N/C N/C N/C 228 410 € 178 841 € 207 174 € 233 978 € 235 959 € 217 061 €
Net margin N/C N/C N/C N/C 7.6% 6.3% 8.0% 8.8% 8.4% 7.8%

Revenue and income statement

In 2025, LA PHARMACIE DU FOUSSERET generates positive net income of 105 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 148 k€ -> 105 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

104 527 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

84.05%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.134%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

58.6%

Solvency indicators evolution
LA PHARMACIE DU FOUSSERET

Sector positioning

Debt ratio
84.05 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average +36 pts over 3 years

In 2025, the debt ratio of LA PHARMACIE DU FOUSSERET (84.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.13% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average -36 pts over 3 years

In 2025, the financial autonomy of LA PHARMACIE DU FOUSSERET (45.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 115.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

115.843

Liquidity indicators evolution
LA PHARMACIE DU FOUSSERET

Sector positioning

Liquidity ratio
115.84 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch

In 2025, the liquidity ratio of LA PHARMACIE DU FOUSSERET (115.84) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LA PHARMACIE DU FOUSSERET

Positioning of LA PHARMACIE DU FOUSSERET in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of LA PHARMACIE DU FOUSSERET is estimated at 1 660 423 € (range 1 126 771€ - 2 605 433€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1126k€ 1660k€ 2605k€
1 660 423 € Range: 1 126 771€ - 2 605 433€
NAF 5 année 2025

Valuation method used

Net Income Multiple
104 527 € × 15.9x = 1 660 424 €
Range: 1 126 771€ - 2 605 434€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare LA PHARMACIE DU FOUSSERET with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about LA PHARMACIE DU FOUSSERET

What is the revenue of LA PHARMACIE DU FOUSSERET ?

The revenue of LA PHARMACIE DU FOUSSERET in 2021 is 2.4 M€.

Is LA PHARMACIE DU FOUSSERET profitable?

Yes, LA PHARMACIE DU FOUSSERET generated a net profit of 105 k€ in 2025.

Where is the headquarters of LA PHARMACIE DU FOUSSERET ?

The headquarters of LA PHARMACIE DU FOUSSERET is located in LE FOUSSERET (31430), in the department Haute-Garonne.

Where to find the tax return of LA PHARMACIE DU FOUSSERET ?

The tax return of LA PHARMACIE DU FOUSSERET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LA PHARMACIE DU FOUSSERET operate?

LA PHARMACIE DU FOUSSERET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.